Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

599 ARTÍCULOS , VIENDO DEL 271 AL 285

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?

O'Hara DM, Pawar G, Kalia SK, Kalia LV.

Front Neurosci. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577. eCollection 2020.

Multiple system atrophy pathology is associated with primary Sjögren's syndrome

Conway KS, Camelo-Piragua S, Fisher-Hubbard A, Perry WR, Shakkottai VG, Venneti S.

JCI Insight. 2020 Aug 6;5(15):e138619. doi: 10.1172/jci.insight.138619.

Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease

Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC.

Neurology. 2020 Sep 15;95(11):e1461-e1470. doi: 10.1212/WNL.0000000000010316. Epub 2020 Jul 10.

What People with Parkinson's Disease Want

Andrejack J, Mathur S.

J Parkinsons Dis. 2020;10(s1):S5-S10. doi: 10.3233/JPD-202107.

Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial

Mestre TA, Freitas E, Basndwah A, Lopez MR, de Oliveira LM, Al-Shorafat DM, Zhang T, Lui JP, Grimes D, Fox SH.

Mov Disord. 2020 Dec;35(12):2319-2323. doi: 10.1002/mds.28196. Epub 2020 Jul 13.

Magnetic resonance-guided focused ultrasound for movement disorders: clinical and neuroimaging advances

Martínez-Fernández R, Pineda-Pardo JA.

Curr Opin Neurol. 2020 Aug;33(4):488-497. doi: 10.1097/WCO.0000000000000840.

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease

Jin Z, Liu Z, Kang L, Yang A, Zhao H, Yan X, Zhang T, Gao L, Liu A, Fang B.

Medicine (Baltimore). 2020 Jul 10;99(28):e21145. doi: 10.1097/MD.0000000000021145.

GLP-1 receptor agonists for Parkinson's disease

Mulvaney CA, Duarte GS, Handley J, Evans DJ, Menon S, Wyse R, Emsley HC.

Cochrane Database Syst Rev. 2020 Jul 23;7(7):CD012990. doi: 10.1002/14651858.CD012990.pub2.

[Insomnia comorbid to Parkinson's disease Part I: Epidemiology, assessment, and related factors]

Lebrun C, Gély-Nargeot MC, Bayard S.

Geriatr Psychol Neuropsychiatr Vieil. 2020 Sep 1;18(3):321-330. doi: 10.1684/pnv.2020.0874.

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses

Riederer P, Ter Meulen V.

J Neural Transm (Vienna). 2020 Sep;127(9):1217-1228. doi: 10.1007/s00702-020-02230-x. Epub 2020 Jul 28.

Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

Artusi CA, Imbalzano G, Sturchio A, Pilotto A, Montanaro E, Padovani A, Lopiano L, Maetzler W, Espay AJ.

Neurotherapeutics. 2020 Oct;17(4):1736-1746. doi: 10.1007/s13311-020-00901-x.

Management of Visual Dysfunction in Patients with Parkinson's Disease

Savitt J, Aouchiche R.

J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.

[Advanced Parkinson's disease characteristics in clinical practice: Results from the OBSERVE-PD study and sub-analysis of the Hungarian data]

Takáts A, Aschermann Z, Vécsei L, Klivényi P, Dézsi L, Zádori D, Valikovics A, Varannai L, Onuk K, Kinczel B, Kovács N.

Ideggyogy Sz. 2020 Jul 30;73(7-08):261-268. doi: 10.18071/isz.73.0261.

Primary Central Nervous System Lymphoma Presenting as Parkinsonism with Atypical MRI Findings and Elevated 14-3-3 Protein

Nagarajan E, Yerram SY, Digala LP, Bollu PC.

J Neurosci Rural Pract. 2020 Jul;11(3):492-494. doi: 10.1055/s-0040-1713300. Epub 2020 Jun 16.

Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

Peball M, Krismer F, Knaus HG, Djamshidian A, Werkmann M, Carbone F, Ellmerer P, Heim B, Marini K, Valent D, Goebel G, Ulmer H, Stockner H, Wenning GK, Stolz R, Krejcy K, Poewe W, Seppi K; Collaborators of the Parkinson's Disease Working Group Innsbruck.

Ann Neurol. 2020 Oct;88(4):712-722. doi: 10.1002/ana.25864. Epub 2020 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias